The final draft of a new round of drug bidding in Anhui was announced

On May 12th, on the Monday of the 12th, the Anhui Provincial Health Planning Commission announced the finalization of a new round of procurement for drug bidding, which is basically consistent with the previously released public consultation draft, and the idea of ​​“supporting low and suppressing high” runs through them.

The new round of drug bidding in Anhui Province was limited to the basic medicines selected in the province's 1118 public hospitals. In the bidding model, it is intended to correct the “low price” of traditional base drug bidding, and the overall attitude is more moderate, continuing the previous “double envelope”. Models, economic and technical standards and business standards are scored according to the ratio of 6:4. Patents, original research, separate pricing and other types of products are included in the high-quality level, giving higher scoring weights, which can avoid price conflicts.

Although the quality tends to be more inclined, Anhui Province still maintains its attitude of “severely killing” the higher quality varieties such as original research and individual pricing. The plan clearly stipulates that for varieties with less than 2 bids for drugs, the winning bid price shall not be higher than 82% of the retail price of the pharmaceutical government. A front-line employee of a foreign drug company indicates to the Great Smart News Agency (WeChat: dzh_news) that “82% The price of the drug is actually lower than the lowest bid price in the country, and the price pressure for this part of the drug is still very high."

However, in contrast to the strict attitude of the aforementioned high-priced drugs, Anhui Province has the greatest degree of “tolerance” for low-priced drugs. After the quality standards have been passed for the varieties of low-cost drugs on the national list and the first batch of low-cost drugs in the province, It is directly linked to the network and purchased by the hospital itself.

Previously, the relevant person in charge of the Anhui Provincial Health and Development Planning Commission had proposed the idea of ​​“lower, higher, and higher” bids, that is, for high-priced drugs, the price was high, and the price space was squeezed through bidding to squeeze out the water. At the same time, the low-cost drugs are directly linked to the network to solve the problem of enterprises' reluctance to deliver and shortage of drugs.